CEO sold ~$99K of Puma Biotechnology
Scheduled in advanceLoading…
Traded Jan 6, 2026 · Filed Jan 9, 2026
Puma Biotechnology's See Remarks sold $23K of Puma Biotechnology shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$23,218
Shares × reported transaction price
61 days after results of Nov 6, 2025, 51 days before results of Feb 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
CEO sold ~$99K of Puma Biotechnology
Scheduled in advanceCEO sold ~$106K of Puma Biotechnology
Scheduled in advanceOfficer sold ~$29K of Puma Biotechnology
Scheduled in advance